首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino(5,4-b)quinoxaline derivatives and evaluation of their antiamoebic activity.
【24h】

Synthesis of new 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino(5,4-b)quinoxaline derivatives and evaluation of their antiamoebic activity.

机译:新的2-(5-取代的-3-苯基-2-吡唑啉基)-1,3-噻唑啉基(5,4-b)喹喔啉衍生物的合成及其抗厌氧活性的评价。

获取原文
获取原文并翻译 | 示例
           

摘要

In an effort to develop potent antiamoebic agents, we have synthesized chalcones (1-8), amino-5-substituted-(3-phenyl(2-pyrazolinyl))methane-1-thione derivatives (1a-8a) and 2-(5-substituted-3-phenyl-2-pyrazolinyl)-1,3-thiazolino[5,4-b]quinoxaline derivatives (1b-8b) and evaluated for their in vitro antiamoebic activity against HM1:IMSS strain of E. histolytica. All the compounds were characterized by electronic, IR, (1)H NMR and mass spectroscopic data. It was observed that the antiamoebic activity enhances on modifying the structure of chalcones to the pyrazolines and further to quinoxalines. The MTT assay was performed on human kidney epithelial cell line to check the cytotoxicity of the compounds and the results were compared with metronidazole. Compound 6b showed better antiamoebic activity and less toxicity than metronidazole.
机译:为了开发有效的抗厌氧剂,我们合成了查耳酮(1-8),氨基-5-取代-(3-苯基(2-吡唑啉基))甲烷-1-硫酮衍生物(1a-8a)和2-( 5-取代的-3-苯基-2-吡唑啉基)-1,3-噻唑啉代[5,4-b]喹喔啉衍生物(1b-8b)并评估了其对溶血性大肠杆菌HM1:IMSS菌株的体外抗厌氧活性。所有化合物均通过电子,IR,(1)H NMR和质谱数据表征。观察到,通过改变查耳酮对吡唑啉和进而对喹喔啉的结构,抗厌氧活性增强。在人肾上皮细胞系上进行MTT测定以检查化合物的细胞毒性,并将结果与​​甲硝唑进行比较。与甲硝唑相比,化合物6b表现出更好的抗氧活性和更低的毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号